Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucophage sachets vs tablets for adherence in type 2 diabetes
NCT01510522Phase 4Withdrawn
- Sponsor
- Merck KGaA
- Start
- Jun 2012
- Primary completion
- Jun 2012
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Merck KGaA. Planned start Jun 2012; status: withdrawn.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01510522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01510522.